Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07135947 · ClinicalTrials.gov registry record · NA

To Evaluate the Clinical Impact of the Point Powered System

A NA study, sponsored by Point Designs.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT07135947: Clinical Trial NA study, sponsored by Point Designs.

NCT07135947 is a NA study that has not yet begun recruiting, run by Point Designs. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07135947, a NA study, has not yet begun recruiting, sponsored by Point Designs.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the efficacy of the Point Powered system as compared to the patient's standard-of-care treatment. This study will be a single subject crossover design where one group of 10 adult partial hand amputees will be evaluated on several metrics on their existing prosthetic treatment (Treatment 1) and the Point Powered system (Treatment 2) over a period of three months using standard two-site myoelectric control. Metrics include: in-clinic functional measures, subjective assessments, bilateral hand use, and prosthesis wear time.

Primary Outcome

The proctor for the measure chooses an everyday activity, such as setting up a table for snacks or replanting a flower, that is relevant to the study population. As the participants perform the chosen task, a trained rater will assess their capacity for control of their myoelectric prosthesis as represented by 30 items reflecting 6 aspects of quality of myoelectric control. These 6 aspects are "the need for external support," "grip force and opening width," "coordination of both hands, "in diffe

Interventions

  • DEVICE Point Powered partial hand prosthetic system

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-09-01
Est. Completion 2027-04-01
Phase NA
Point Designs

7 total trials

What is known before NCT07135947 opens enrollment

NCT07135947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Point Powered partial hand prosthetic system is the first listed.

NCT07135947 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07135947 about?

NCT07135947 is a clinical study titled "To Evaluate the Clinical Impact of the Point Powered System". The objective of this study is to evaluate the efficacy of the Point Powered system as compared to the patient's standard-of-care treatment. This study will be a single subject crossover design where one group of 10 adult partial hand amputees will be evaluated on several metrics on their existing p...

What is the current status of trial NCT07135947?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-09-01. Estimated completion is 2027-04-01.

What interventions are being tested in trial NCT07135947?

The interventions under investigation include: Point Powered partial hand prosthetic system (DEVICE).

Who is sponsoring clinical trial NCT07135947?

This trial is sponsored by Point Designs, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07135947's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07135947, the US trial registry maintained by the National Library of Medicine. NCT07135947 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.